OQROSign up free
Politician trade (House)

Vertex Pharmaceuticals (VRTX): Rep. David J. Taylor (OH02) disclosed a sale $1K–$15K

Rep. David J. Taylor (OH02) disclosed a sale of Vertex Pharmaceuticals in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
4 days
Disclosure lag
Traded
Jan 29, 2026
Disclosed
Feb 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024Congress · 1 personMembers of Congress: 2 purchases
  2. Dec 3, 2025Insider · 4 peopleInsiders: 16 sales (~$37.2M)
  3. Jan 6, 2026Insider · Their largest sale since 2020Officer sold ~$4.39M of VRTX shares in the open market
  4. Jan 7, 2026InsiderOfficer sold ~$2.14M of VRTX shares in the open market
  5. Jan 29, 2026 · this disclosureCongressDisclosed sale of VRTX — reported range $1,001 - $15,000

What came next

  1. Feb 11, 2026Insider · 5 peopleInsiders: 5 sales (~$3.5M)
  2. Feb 12, 2026Company filing · Form 8-K · ResultsReported its results
  3. Feb 12, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 6.8%
  4. Feb 13, 2026Insider · 3 peopleInsiders: 3 sales (~$1.4M)
  5. Feb 17, 2026Insider · 5 peopleInsiders: 5 sales (~$4.5M)
  6. Feb 18, 2026Insider · 5 peopleInsiders: 5 sales (~$2.0M)
  7. Feb 19, 2026Insider · 1 personInsiders: 8 sales (~$27.5M)
  8. Feb 25, 2026Insider · 7 peopleInsiders: 8 sales (~$4.6M)
  9. Feb 26, 2026InsiderOfficer sold ~$173K of VRTX shares in the open market
  10. Feb 27, 2026Insider · 2 peopleInsiders: 14 sales (~$20.9M)
  11. Mar 2, 2026InsiderOfficer sold ~$442K of VRTX shares in the open market
  12. Mar 4, 2026InsiderOfficer sold ~$1.16M of VRTX shares in the open market
  13. Mar 11, 2026InsiderOfficer sold ~$1.31M of VRTX shares in the open market
  14. Mar 13, 2026InsiderOfficer sold ~$1.12M of VRTX shares in the open market
  15. Mar 27, 2026FDAFDA drug approval: Alyftrek
  16. Mar 27, 2026FDAFDA drug approval: Trikafta (Copackaged)
  17. Mar 27, 2026FDAFDA drug approval: Trikafta (Copackaged)
  18. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  19. Mar 27, 2026InsiderOfficer sold ~$1.05M of VRTX shares in the open market
  20. Apr 1, 2026InsiderOfficer sold ~$439K of VRTX shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

Other recent filings by Rep. David J. Taylor (OH02)

The full history of Rep. David J. Taylor (OH02) is on the profile page.

How this filing works

Explore the data

Other disclosures at Vertex Pharmaceuticals

Everything OQRO holds on this company is on its VRTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data